Company Data
SELLAS Life Sciences Group Inc.
Ticker
SLS
Current Price
$12.85 -3.67%
Market Cap
$2.6B
Price Target
Refer to Report
Volume
2.6M
52wk Range
$1.39 - $15.8765
Overview
SELLAS Life Sciences Group Inc is a biopharmaceutical company. The company is engaged in the development of novel cancer immunotherapies for a broad range of cancer indications. Its pipeline products are Galinpepimut-S, Nelipepimut-S, GALE-301/-302 and NeuVax.